Mutations in BRCA2 confer a higher risk for developing cancers of the pancreas and male breast, and BRCA1 mutations seem to be predominantly associated with a higher risk for developing peritoneal and fallopian tube cancer. This evidence concerns the gene BRCA1 and fallopian tube cancer.